Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Immunome (IMNM)
NASDAQ:IMNM
Holding IMNM?
Track your performance easily
IMNM Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$6.93 - $30.96
Previous Close$9.33
Volume662.96K
Average Volume (3M)695.70K
Market Cap
$586.09M
Enterprise Value$348.36M
Total Cash (Recent Filing)$240.20M
Total Debt (Recent Filing)$2.46M
Price to Earnings (P/E)―
Beta2.01
Next Earnings
Mar 26, 2025EPS Estimate
-$0.66Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-8.12
Shares Outstanding62,416,845
10 Day Avg. Volume1,039,151
30 Day Avg. Volume695,696
Standard Deviation0.42
R-Squared0.04
Alpha0.04
Financial Highlights & Ratios
Price to Book (P/B)2.71
Price to Sales (P/S)57.86
Price to Cash Flow (P/CF)-4.30
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue34.39
Enterprise Value/Gross Profit24.85
Enterprise Value/Ebitda-1.71
Forecast
1Y Price Target
$26.75Price Target Upside183.97% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering5
Immunome News
PremiumCompany Announcements
Immunome, Inc. Reports Q3 2024 Financial Results
Ownership Overview
1.52% Insiders
20.29% Mutual Funds
39.22% Other Institutional Investors
27.56% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products
IMNM FAQ
What was Immunome’s price range in the past 12 months?
Immunome lowest stock price was $6.93 and its highest was $30.96 in the past 12 months.
What is Immunome’s market cap?
Currently, no data Available
When is Immunome’s upcoming earnings report date?
Immunome’s upcoming earnings report date is Mar 26, 2025 which is in 125 days.
How were Immunome’s earnings last quarter?
Immunome released its earnings results on Nov 13, 2024. The company reported -$0.78 earnings per share for the quarter, missing the consensus estimate of -$0.551 by -$0.229.
Is Immunome overvalued?
According to Wall Street analysts Immunome’s price is currently Undervalued.
Does Immunome pay dividends?
Immunome does not currently pay dividends.
What is Immunome’s EPS estimate?
Immunome’s EPS estimate is -$0.66.
How many shares outstanding does Immunome have?
Immunome has 62,416,843 shares outstanding.
What happened to Immunome’s price movement after its last earnings report?
Immunome reported an EPS of -$0.78 in its last earnings report, missing expectations of -$0.551. Following the earnings report the stock price went down -3.883%.
Which hedge fund is a major shareholder of Immunome?
Among the largest hedge funds holding Immunome’s share is Woodline Partners LP. It holds Immunome’s shares valued at 14M.
---
Immunome Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$26.75 (183.97% Upside)
$26.75 (183.97% Upside)
Blogger Sentiment
Bullish
IMNM Sentiment 100%
Sector Average 72%
Sector Average 72%
Hedge Fund Trend
Increased
By 13.5K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $230.2K over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Negative
Last 7 Days ▼ 4.1%
Last 30 Days ▼ 8.3%
Last 30 Days ▼ 8.3%
Technicals
SMA
Negative
20 days / 200 days
Momentum
19.76%
12-Months-Change
Fundamentals
Return on Equity
-276.36%
Trailing 12-Months
Asset Growth
175.76%
Trailing 12-Months
Company Description
Immunome
Immunome Inc is a biopharmaceutical company engaged in the discovery and development of novel antibody-based drugs. The company's proprietary discovery platform identifies novel therapeutic antibodies and their targets by leveraging highly educated components of the immune system, memory B cells, from patients who have learned to fight off their disease. It is developing treatments for treating cancer and other infectious diseases.
---
IMNM Stock 12 Month Forecast
Average Price Target
$26.75
▲(183.97% Upside)
Technical Analysis
Best Analysts Covering IMNM
1 Year
1 Year Success Rate
1/9 ratings generated profit
1 Year Average Return
-32.07%
reiterated a buy rating 8 days ago
Copying David Nierengarten's trades and holding each position for 1 Year would result in 11.11% of your transactions generating a profit, with an average return of -32.07% per trade.
---